SCHEMBL23558395

SCHEMBL23558395

CCC1(CC)CC(=O)c2cc(-c3cc(-c4ccc5c(c4)C=C(O)C5)no3)ccc2O1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.38
▸ ABCC1 P33527 1/20 0.38
▸ RARA P10276 1/20 0.34
▸ RARB P10826 1/20 0.34
▸ RARG P13631 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ NPC1 O15118 5/20 0.32
▸ RAB9A P51151 5/20 0.32
▸ HSD17B1 P14061 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31
▸ SIRT5 Q9NXA8 1/20 0.31
▸ KCNH2 Q12809 2/20 0.31
▸ AKT1 P31749 1/20 0.30
▸ PRKD1 Q15139 1/20 0.30
▸ S1PR1 P21453 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25863749 0.84 ABCB1 (0.35) ABCB1ABCC1RARARARBRARG
SCHEMBL23558461 0.82 NPC1 (0.45) ABCB1ABCC1CNR1CNR2KMT2A
SCHEMBL25856895 0.81 RAB9A (0.42) ABCB1ABCC1MAPTCNR1CNR2
SCHEMBL25856900 0.81 MAOB (0.43) ABCB1ABCC1MAPTCNR1CNR2
SCHEMBL25863238 0.80 CXCR1 (0.40) ABCB1ABCC1CNR1CNR2NPC1
SCHEMBL25856526 0.80 ABCB1 (0.32) ABCB1ABCC1NPC1RAB9AS1PR1
SCHEMBL23558238 0.79 ALDH1A1 (0.45) MAPTKMT2ANPC1RAB9A
SCHEMBL25856856 0.78 NPC1 (0.43) ABCB1ABCC1MAPTCNR1CNR2
SCHEMBL25856949 0.78 CNR1 (0.41) ABCB1ABCC1MAPTCNR1CNR2
SCHEMBL23558404 0.77 ABCB1 (0.51) ABCB1ABCC1RARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 ABCB1 3052/4885ABCC1 2927/4885RARA 2813/4885
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 ABCB1 3052/4885ABCC1 2927/4885RARA 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback